Viewing Study NCT06670105


Ignite Creation Date: 2025-12-25 @ 3:26 AM
Ignite Modification Date: 2025-12-31 @ 10:54 PM
Study NCT ID: NCT06670105
Status: WITHDRAWN
Last Update Posted: 2025-09-17
First Post: 2024-10-31
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Phase 2 Trial of Glofitamab for Minimal Residual Disease in Patients With Large B-cell Lymphoma
Sponsor: M.D. Anderson Cancer Center
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module